Financials Toleranzia AB

Equities

TOL

SE0007438577

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:17:10 2024-04-29 am EDT 5-day change 1st Jan Change
0.522 SEK -1.14% Intraday chart for Toleranzia AB +2.76% +21.96%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 32.61 46.91 68.86 82.88 130.2 123.6
Enterprise Value (EV) 1 26.67 31.45 48.86 40.58 54.74 90.47
P/E ratio -6.05 x -6.28 x -7.2 x -9.13 x -13.3 x -14.6 x
Yield - - - - - -
Capitalization / Revenue 12.9 x 11 x 9.91 x 6.43 x 4.72 x 3.49 x
EV / Revenue 10.5 x 7.35 x 7.03 x 3.15 x 1.98 x 2.56 x
EV / EBITDA -4.96 x -5.58 x -9.42 x -8.29 x -8.74 x -10.5 x
EV / FCF -4.31 x -4.53 x -5.76 x -2.96 x -1.77 x -2.3 x
FCF Yield -23.2% -22.1% -17.3% -33.8% -56.4% -43.4%
Price to Book 2.22 x 1.7 x 1.97 x 1.22 x 1.02 x 1.03 x
Nbr of stocks (in thousands) 7,993 15,534 20,194 54,346 110,315 110,315
Reference price 2 4.080 3.020 3.410 1.525 1.180 1.120
Announcement Date 4/27/18 4/30/19 4/28/20 4/12/21 4/6/22 4/6/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 2.532 4.278 6.949 12.88 27.59 35.37
EBITDA 1 -5.378 -5.635 -5.186 -4.893 -6.266 -8.622
EBIT 1 -5.406 -5.66 -5.203 -4.913 -6.282 -8.639
Operating Margin -213.46% -132.31% -74.88% -38.14% -22.77% -24.43%
Earnings before Tax (EBT) 1 -5.392 -5.658 -7.56 -4.894 -6.249 -8.456
Net income 1 -5.392 -5.658 -7.56 -4.894 -6.249 -8.456
Net margin -212.93% -132.26% -108.78% -38% -22.65% -23.91%
EPS 2 -0.6746 -0.4810 -0.4734 -0.1671 -0.0888 -0.0767
Free Cash Flow 1 -6.194 -6.947 -8.476 -13.71 -30.86 -39.3
FCF margin -244.62% -162.4% -121.97% -106.42% -111.86% -111.11%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/27/18 4/30/19 4/28/20 4/12/21 4/6/22 4/6/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 5.94 15.5 20 42.3 75.4 33.1
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -6.19 -6.95 -8.48 -13.7 -30.9 -39.3
ROE (net income / shareholders' equity) -31.1% -26.8% -24.2% -9.51% -6.38% -6.83%
ROA (Net income/ Total Assets) -17.3% -15% -9.42% -5.52% -3.83% -4.19%
Assets 1 31.17 37.71 80.24 88.64 163 201.9
Book Value Per Share 2 1.830 1.780 1.730 1.250 1.160 1.080
Cash Flow per Share 2 0.8700 1.050 1.030 0.7900 0.6900 0.3100
Capex - - - 0.08 - 0.05
Capex / Sales - - - 0.62% - 0.13%
Announcement Date 4/27/18 4/30/19 4/28/20 4/12/21 4/6/22 4/6/23
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. TOL Stock
  4. Financials Toleranzia AB